 Home > Medical News >

Medical Research Articles

FDA accepts new drug application from GBT's SCD therapy voxelotor

 Time of Update: 2020-06-08

panc 1 cells mg 3 red marrow function crispr clinical trial clinical development

Global ( http:// announced that the u.S FDA (http:// had accepted the company's application for new drug (http:// (NDA) for the oral sickle cell anemia (SCD) treatment About Voxelotor Voxe
Johnson and Johnson's Posson Tatterser gets NMPA approval to treat pulmonary hypertension in children

 Time of Update: 2020-06-08

amlodipine brand name cotrimoxazole brand name ph levels body pregabalin generic name sertraline brand name

recently, Johnson and Johnson's Janssen Pharmaceutical (http:// company (http:// Actelion announced that Posson tatters (full-®, English brand name: Tracleer, generic name: bosentan) (spec: 32m
Xuno Pharmaceuticals officially launched Abesta for treatment of lymphoma, renal cell carcinoma II, Phase III clinical

 Time of Update: 2020-06-08

rabeprazole side effects vancomycin side effects stage iii breast cancer bravecto side effects bilberry side effects

Recently, Abexinostat of Xuno Pharmaceuticals officially launched Phase II and III clinical treatment for lymphoma and renal cell carcinoma About Abestas Abes is the first candidate drug (http:
Paclitaxel and encequidar combined to treat breast cancer in key phase 3 clinical study reached the main endpoint

 Time of Update: 2020-06-08

serc 24 mg mg 2 therapeutic marinol 2.5 mg pregabalin 150 mg

Today, Athenex (http:// announce its oral formula, which combines paclitaxel and encequidar, to reach the main point in a key Phase 3 clinical study to treat metastatic breast cancer About Enceq
AstraZeneca Tagrisso treats NSCLC patients with Phase 3 clinical trials with positive results

 Time of Update: 2020-06-08

3 10 helix humira drug mobic drug negative control group stadol drug

recently, AstraZeneca (http:// announced that its heavyweight third-generation EGFR inhibitor Tagrisso (osimertinib, oxitinib) has achieved positive results in the of a critical phase 3 clinical
Karyopharm's innovative therapy Xpovio (selinexor) Phase 2b clinical trial yields positive results

 Time of Update: 2020-06-08

which function proteins iv anti inflammatory dexamethasone oral hazard class 3 stage 3 neuroblastoma

recently, Karyopharm Therapeutics company (http:// announced positive results from the of its innovative clinical (http:// for the treatment of recurrent/incurable multiple myeloma study was
FDA approves Novartis Beovu ® injection to treat wet macular degeneration

 Time of Update: 2020-06-08

fda approved biosimilars phase change solutions crispr human trials infigratinib fda approval vegf

Novartis (http:// announced that the U.S Food drug (http:// Regulatory Authority ( FDA (http:// ) approved the Beovu ® , also known as RTH258, for the treatment of age-related wet macular deg
FDA approves first triple-a-turalio (pexidartinib) for treatment of adult patients with symptomatic tendoncytoma

 Time of Update: 2020-06-08

gamma 1 3 bx795 clinical trials 1 2 addition pd 1 cell small molecule

TGCT, also known as pigmentation fluffy conjure skateitis (PVNS), or tendon cytoblastoma (GCT-TS), is a rare non-malignant tumor with localized aggression Recently, the U.S FDA (http:// announce
Intercept submits new drug Oberonic acid to FDA for new drug for FIbrosis caused by NASH

 Time of Update: 2020-06-08

sunscreen fda approved anoro side effects ginger extract liquid donepezil adverse effects miralax adverse effects

recently, Intercept submitted to the U.S FDA (http:// for the market of its new drug, http:// which is used in NASH-induced fibrosis Recently, the European Commission (EC) has approved the E
FDA approves Xeris ready-to-use glutagon Gvoke injection application

 Time of Update: 2020-06-08

1 ml testosterone acyclovir 400 mg moxifloxacin 400 mg trental 400 mg fda stability guidance

recently, Xeris Pharmaceuticals announced that FDA (http:// approved its application for a market application for a ready-to-use glucagon Gvoke injection to treat severe hypoglycemia Gvoke has t
FDA grants SpringWorks nirogacestat breakthrough treatment

 Time of Update: 2020-06-08

microvascular disease treatment multiple myeloma radiology ind clinical trial gamma 1 2 coli growth rate

hard fibroids are a rare soft tissue tumor that is deactivation and can lead to disfigurement It can quickly invade the surrounding healthy (http:// tissue, causing severe pain, internal bleeding
CHMP recommends approval of Lonsurf for treatment of adult patients with metastatic stomach cancer

 Time of Update: 2020-06-08

dog dna results double stranded dna antibody 1 2 bh stage iii colon cancer cancer stage iiia

Recently, French drugmaker Servier and partner Tai ho Pharmaceutical http:// announced that the European Medicines (http:// Authority ( http:// Products (http:// Committee for human medicin
Berry Bio Entekave generic spree application approved by FDA

 Time of Update: 2020-06-08

debut chronic hepatitis chinese food avon fda drug regulations bio

Recently, the ubiah bio pharmaceutical (http:// (Suzhou) limited shares company (http:// of the Entikave tablets Pharmaceutical (http:// application (http:// was approved by the U.S Food M
FDA approves Nabriva's innovative antibiotic Xenleta (lefamulin) for use in treatment of CABP

 Time of Update: 2020-06-08

fda dietary guidelines bacterial growth media klebsiella pneumonia what cause infectious disease get pneumonia vaping

Community Acquired Bacterial Pneumonia (CABP), a bacterial pneumonia that is developed outside the hospital environment, is one of the most common infectious diseases that threatens health (http:/
FDA grants LENVIMA and KEYTRUDA combination therapies for the treatment of hepatocellular cancer patients

 Time of Update: 2020-06-08

emperor chinese food high protein what cancer patients eat cell study guide eagle chinese food

recently, Aisho and Mershadon announced that the U.S Food medicine (http:// Regulatory Authority ( FDA (http:// ) has awarded LENVIMA (Chinese product name "LeWeima") and KEYTRUDA (Chinese commo
FDA approves gene Tektrone (Merycin) in combination with glucocorticoids for use in children's GPA and MPA

 Time of Update: 2020-06-08

rituximab rheumatoid arthritis pregnancy diflucan single dose natural treatment diabetes new treatment tourette's

recently, Swiss Pharmaceutical (http:// giant Roche's GeneTek announced that the U.S Food and Drug (http:// Authority ( FDA (http:// ) has approved Rituxan (Mera, rituximab, ritusxima) in co
FDA grants Astex pharmaceutical anti-cancer drug ASTX727 orphan drug

 Time of Update: 2020-06-08

bone marrow cells anti drug antibodies west hartford jobs west coast cooler noonan syndrome treatment

recently, Japanese pharmaceutical company Otsuka Pharmaceuticals (http:// wholly-owned sub- company (http:// Astex Pharmaceuticals announced that the U.S Food and Drug (http:// Administrati
FDA agrees to PharmaMar to file claim for new drug by Zepsyre ®

 Time of Update: 2020-06-08

chloral hydrate drug heroin drug class investigational new drug secondary water treatment curamin drug interactions

The u.S Food and drug (http:// Regulatory Authority ( FDA ) has agreed to approve The (http:// application for® a second-line single-drug treatment for small cell lung cancer, the of the F
FDA grants Brynering Ingeheim's breakthrough therapy designation

 Time of Update: 2020-06-08

lung tissue type rat lung disease symptoms vascular endothelial growth factor united states gymnastics factor pairs 52

today, the http:// of the of the of the bouring fdae company announced that the U.S FDA (http:// granted its small molecule tyrosine kinase inhibitor, Ofev (nintedanib), as a breakthrough ther
FDA has granted Aeglea's Pegzilarginase Breakthrough Treatment

 Time of Update: 2020-06-08

ferritin level 3 clinical omics physical therapy midland paragon physical therapy ketamine clinical trials

ARG1-D, also known as arginineemia, is a rare genetic disorder Patients due to mutations in the ARG1 gene, resulting in the lack of argininase 1 in the liver, arginine metabolism disorders Aeglea B

Go to Page

Medical Research Articles

FDA accepts new drug application from GBT's SCD therapy voxelotor

Johnson and Johnson's Posson Tatterser gets NMPA approval to treat pulmonary hypertension in children

Xuno Pharmaceuticals officially launched Abesta for treatment of lymphoma, renal cell carcinoma II, Phase III clinical

Paclitaxel and encequidar combined to treat breast cancer in key phase 3 clinical study reached the main endpoint

AstraZeneca Tagrisso treats NSCLC patients with Phase 3 clinical trials with positive results

Karyopharm's innovative therapy Xpovio (selinexor) Phase 2b clinical trial yields positive results

FDA approves Novartis Beovu ® injection to treat wet macular degeneration

FDA approves first triple-a-turalio (pexidartinib) for treatment of adult patients with symptomatic tendoncytoma

Intercept submits new drug Oberonic acid to FDA for new drug for FIbrosis caused by NASH

FDA approves Xeris ready-to-use glutagon Gvoke injection application

FDA grants SpringWorks nirogacestat breakthrough treatment

CHMP recommends approval of Lonsurf for treatment of adult patients with metastatic stomach cancer

Berry Bio Entekave generic spree application approved by FDA

FDA approves Nabriva's innovative antibiotic Xenleta (lefamulin) for use in treatment of CABP

FDA grants LENVIMA and KEYTRUDA combination therapies for the treatment of hepatocellular cancer patients

FDA approves gene Tektrone (Merycin) in combination with glucocorticoids for use in children's GPA and MPA

FDA grants Astex pharmaceutical anti-cancer drug ASTX727 orphan drug

FDA agrees to PharmaMar to file claim for new drug by Zepsyre ®

FDA grants Brynering Ingeheim's breakthrough therapy designation

FDA has granted Aeglea's Pegzilarginase Breakthrough Treatment